Those who suffered eye damage and/or vision loss after taking the bladder medication Elmiron for at least one year may qualify for financial compensation through an Elmiron vision loss lawsuit. Please contact Lerner and Rowe Injury Attorneys today for a free no-obligation case evaluation.
The drug manufacturer may be obligated to provide compensation for your injuries and other damages to include: lost wages, medical expenses, loss of enjoyment of life, mental anguish, emotional distress, and others.
Vision Loss Allegation Against Elmiron Drugmaker
Elmiron (pentosan polysulfate sodium) is manufactured by Janssen Pharmaceuticals. The drug was approved for consumer use by the U.S. Food & Drug Administration (FDA) on September 26, 1996 for the treatment of interstitial cystitis (IC).
100mg Elmiron is a white oblong-shaped pill that is prescribed to be taken three times a day.
Recently the American Academy of Ophthalmology shared results linking maculopathy, a vision-threatening eye condition, to prolonged use of this bladder drug.
Patients who have filed Elmiron lawsuits allege that Janssen Pharmaceuticals failed to properly warn against risk of maculopathy or blindness. This potential side effect is not listed among the other warnings found on drug packaging. Additionally, Janssen Pharmaceuticals had knowledge of, or should have known, that pentosan polysulfate sodium could cause maculopathy.
How Does Elmiron Work?
Elmiron is an oral capsule that is usually prescribed for interstitial cystitis (IC)– a chronic health condition that causes bladder pain and pressure, increases urinary frequency and urgency, as well as overall pelvic pain in both women and men.
Elmiron is thought to work by acting as a synthetic layer that coats the bladder wall that then protects the bladder from coming in direct contact with irritating substances.
Signs of Maculopathy in Elmiron Patients
Patients who have taken Elmiron for a prolonged amount of time have contacted their doctor after noticing these vision problems:
- Dimming of vision
- Blurred vision
- Difficulty seeing objects up close
- Find it more difficult adjusting to the dark
- Noticing a blindspot in their field of vision
Do You Have an Elmiron Vision Loss Case?
At Lerner and Rowe Injury Attorneys, our legal team encourages anyone who has been diagnosed with an eye disorder or vision problems after taking prescription Elmiron for over a year to contact our firm. Call us directly at 844-977-1900, chat with a live representative now, or share more details through an online form.
Specific vision loss claims we are currently reviewing include:
- Pigmentary maculopathy
- Degenerative maculopathy/macular degeneration
- Macular retinopathy
- Macular/pattern dystrophy
- Retinal pigment epithelium atrophy resulting in scotomas
- Unilateral or bilateral blindness
Make one call to our Elmiron vision loss lawyers now to learn more about your legal options. You may be entitled to substantial financial compensation for injuries, losses, and other subsequent damages.